Skip to main content

Advertisement

Table 4 Univariate and multivariate analyses of stage I/II disease-free survival and stage III/IV overall survival

From: Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection

  Univariate Analysis Multivariate Analysis Univariate Analysis Multivariate Analysis
Clinical Factors Recurrences/No. of Patients (stage I/II) Log-Rank P Risk Ratio (95%CI) Wald P Deaths/No. of Patients (stage III/IV) Log-Rank P Risk Ratio (95%CI) Wald P
Sex   0.314 1.0 NS   0.337 1.0 NS
Female 9/37     42/71    
Male 9/54     43/64    
Age, years 0.999 1.0 NS   <0.001 3.753 <0.001
<70 13/65     58/99   (1.746-8.070)  
≥70 5/26     27/36    
TNM stage 0.222 1.0 NS   0.084 1.0 NS
p I 0/8        
p II 18/83        
p III      82/127    
p IV      3/8    
Tumor invasion 0.408 1.0 NS   0.842 1.0 NS
pT1 0/1        
pT2 0/7     3/4    
pT3 18/77     79/125    
pT4 0/6     3/6    
Lymph node NO. /metastasis 0.006 1.0 NS   <.001 4.450 <.001
0-7/pN0 9/25     2/8   (2.675-7.401)  
8–12/pN1 4/48     65/105    
>12/pN2 5/18     18/22    
Grade   0.329 1.0 NS   0.132 1.0 NS
Well 6/28     18/29    
Moderate 8/50     55/90    
Poor 4/13     12/16    
Tumor size, cm 0.049 1.0 0.099   0.249 1.0 NS
<2 2/20     25/37    
2-5 12/63     42/72    
>5 4/8     18/26    
Location 0.164 1.0 NS    0.440 1.0 NS
Colon 11/40     44/75    
Rectum 7/51     41/60    
CXCL14   0.018 2.92 (1.15-7.40) 0.024   0.003 3.087 (1.866-5.107) <0.001
Low 10/69     39/68    
High 8/22     46/67    
  1. Abbreviation: NS, not significant.